Medicare Enrolled
Dr. Nisha Vashishta, MD
Family Medicine · Mt Pleasant, MI
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Vashishta from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Vashishta?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Vashishta
Dr. Nisha Vashishta is a family medicine specialist in Mt Pleasant, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Vashishta performed 1,547 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Vashishta received a total of $5,447 from 36 pharmaceutical and/or device companies across 343 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Vashishta is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 10% volume in MI
$5,447 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,547
Medicare services
Top 10% in MI for family medicine
Not available
Unique patients (not deduplicated)
$63
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
433 | $82 | $175 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
181 | $59 | $125 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
137 | $10 | $25 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
100 | $125 | $225 |
| Annual depression screening | 97 | $18 | $35 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
89 | $58 | $125 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
83 | $29 | $40 |
| Assessment of emotional or behavioral problems An evaluation to identify and understand emotional or behavioral issues. This process involves reviewing symptoms and behaviors to determine the nature of the concerns. |
79 | $3 | $25 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
54 | $76 | $95 |
| COVID-19 vaccine administration Administration of a single dose of the coronavirus vaccine. |
46 | $39 | $50 |
| COVID-19 vaccine (Pfizer bivalent) Administration of a 30 mcg dose of the SARS-CoV-2 vaccine via intramuscular injection. |
46 | $128 | $150 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
38 | $10 | $45 |
| SARS-CoV-2 vaccine, 30 mcg/0.3 mL Administration of the SARS-CoV-2 (COVID-19) vaccine containing 30 micrograms of antigen in a 0.3 milliliter dose. |
34 | $39 | $50 |
| Quadrivalent influenza vaccine, cell-culture derived A flu shot containing four strains of influenza virus, produced using cell culture technology rather than eggs. This formulation is free from preservatives and antibiotics. |
29 | $33 | $55 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
28 | $213 | $415 |
| Pneumococcal conjugate vaccine (PCV20) An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria. |
21 | $282 | $300 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
21 | $29 | $40 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
16 | $3 | $10 |
| Fecal immunochemical test (FIT), 1-3 simultaneous A screening test that uses a stool sample to detect hidden blood in the feces, helping to identify potential colorectal cancer. |
15 | $18 | $30 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$5,447
Total received (2018-2024)
Avg $778/year across 7 years
Top 8% in MI for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
36
Companies
343
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,157
2023
$815
2022
$890
2021
$927
2020
$424
2019
$600
2018
$634
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$174
Novo Nordisk Inc
$161
Boehringer Ingelheim Pharmaceuticals, Inc.
$153
Lilly USA, LLC
$143
PFIZER INC.
$80
Neurelis, Inc.
$64
GlaxoSmithKline, LLC.
$63
E.R. Squibb & Sons, L.L.C.
$59
Exact Sciences Corporation
$46
Otsuka America Pharmaceutical, Inc.
$45
ABBVIE INC.
$36
Radius Health, Inc.
$33
Mylan Specialty L.P.
$31
Astellas Pharma US Inc
$20
Novartis Pharmaceuticals Corporation
$18
Phathom Pharmaceuticals, Inc.
$17
Esperion Therapeutics, Inc.
$14
Top 3 companies account for 42.1% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$834
Boehringer Ingelheim Pharmaceuticals, Inc.
$777
Lilly USA, LLC
$632
Novo Nordisk Inc
$627
Novartis Pharmaceuticals Corporation
$314
PFIZER INC.
$291
Mylan Specialty L.P.
$182
GlaxoSmithKline, LLC.
$181
Merck Sharp & Dohme Corporation
$172
Janssen Pharmaceuticals, Inc
$161
Exact Sciences Corporation
$124
Amgen Inc.
$110
Abbott Laboratories
$103
Neurelis, Inc.
$85
E.R. Squibb & Sons, L.L.C.
$84
Radius Health, Inc.
$71
AbbVie Inc.
$70
SANOFI-AVENTIS U.S. LLC
$65
ABBVIE INC.
$59
Amarin Pharma Inc.
$58
Esperion Therapeutics, Inc.
$50
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$46
Astellas Pharma US Inc
$46
Otsuka America Pharmaceutical, Inc.
$45
ACADIA Pharmaceuticals Inc
$42
JAZZ PHARMACEUTICALS INC.
$42
Sunovion Pharmaceuticals Inc.
$28
Melinta Therapeutics, Inc.
$25
Becton, Dickinson and Company
$18
Avanir Pharmaceuticals, Inc.
$18
Phathom Pharmaceuticals, Inc.
$17
Daiichi Sankyo Inc.
$16
Biohaven Pharmaceutical Holding Company Ltd.
$16
Bardy Diagnostics, Inc.
$13
NESTLE HEALTHCARE NUTRITION INC.
$13
Allergan Inc.
$12
Top 3 companies account for 41.2% of all-time payments
Associated products mentioned in payments ›
AIMOVIG · AIRSUPRA · Aimovig · BASAGLAR · BD Affirm VPIII Microbial Identification Test · BEVESPI AEROSPHERE · BREZTRI · BREZTRI AEROSPHERE · Baxdela · COLOGUARD DNA CAPTURE REAGENTS · Carnation Ambulatory Monitor · Cologuard Collection Kit · ELIQUIS · EMGALITY · ENTRESTO · EPIDIOLEX · EVENITY · FARXIGA · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · INJECTAFER · INVOKANA · JANUVIA · JARDIANCE · LEQVIO · LINZESS · LOKELMA · LONHALA MAGNAIR · MOUNJARO · MYRBETRIQ · NEXLETOL · NUCALA · NUPLAZID · NURTEC ODT · Nuedexta · Otezla · Ozempic · PREVNAR 13 · PREVNAR 20 · Perforomist · Proclaim IPG · REXULTI · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SPIRIVA RESPIMAT · SPRAVATO · STIOLTO RESPIMAT · SYMBICORT · Saxenda · TOVIAZ · TRADJENTA · TRELEGY ELLIPTA · TRULICITY · Tresiba · Tymlos · UTIBRON · VALTOCO · VOQUEZNA · VRAYLAR · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XIFAXAN · YUPELRI · Yupelri · ZENPEP · ZEPBOUND
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Family medicine physicians in nearby ZIP areas
160
County median income
$53,759
Nearest hospital to ZIP centroid (approximate)
MCLAREN CENTRAL MICHIGAN
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Vashishta is a clinical cardiology specialist, with above-average Medicare volume (top 10% in MI), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Vashishta experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Vashishta performed 433 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Vashishta receive payments from pharmaceutical companies?
Yes. Dr. Vashishta received a total of $5,447 from 36 companies across 343 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Vashishta's costs compare to other family medicine physicians in Mt Pleasant?
Dr. Vashishta's average Medicare payment per service is $63. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Vashishta) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Mt Pleasant
Browse family medicine physicians in Mt Pleasant ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in MI
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in MI
Which MI family medicine physicians receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology